301 related articles for article (PubMed ID: 23683809)
41. Non-tuberculous mycobacterial lung disease in patients with bronchiectasis: perceived risk, severity and guideline adherence in a European physician survey.
Wagner D; van Ingen J; van der Laan R; Obradovic M;
BMJ Open Respir Res; 2020 Apr; 7(1):. PubMed ID: 32332023
[TBL] [Abstract][Full Text] [Related]
42. High incidence of non-tuberculous mycobacteria-positive cultures among adolescent with cystic fibrosis.
Cavalli Z; Reynaud Q; Bricca R; Nove-Josserand R; Durupt S; Reix P; Perceval M; de Montclos MP; Lina G; Durieu I
J Cyst Fibros; 2017 Sep; 16(5):579-584. PubMed ID: 28202251
[TBL] [Abstract][Full Text] [Related]
43. Nontuberculous mycobacterial lung infections in Ontario, Canada: clinical and microbiological characteristics.
Marras TK; Mehta M; Chedore P; May K; Al Houqani M; Jamieson F
Lung; 2010 Aug; 188(4):289-99. PubMed ID: 20383715
[TBL] [Abstract][Full Text] [Related]
44. Microscopic polyangiitis secondary to Mycobacterium abscessus in a patient with bronchiectasis: a case report.
Addy C; Doran G; Jones AL; Wright G; Caskey S; Downey DG
BMC Pulm Med; 2018 Nov; 18(1):170. PubMed ID: 30453935
[TBL] [Abstract][Full Text] [Related]
45. Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis.
Kunst H; Wickremasinghe M; Wells A; Wilson R
Eur Respir J; 2006 Aug; 28(2):352-7. PubMed ID: 16611651
[TBL] [Abstract][Full Text] [Related]
46. Nontuberculous Mycobacteria in Noncystic Fibrosis Bronchiectasis.
Bonaiti G; Pesci A; Marruchella A; Lapadula G; Gori A; Aliberti S
Biomed Res Int; 2015; 2015():197950. PubMed ID: 26106603
[TBL] [Abstract][Full Text] [Related]
47. Impacts of Nontuberculous Mycobacteria Isolates in Non-cystic Fibrosis Bronchiectasis: A 16-Year Cohort Study in Taiwan.
Lin CY; Huang HY; Hsieh MH; Fang YF; Lo YL; Lin SM; Huang YT; Yeh CH; Wang CH; Lin HC
Front Microbiol; 2022; 13():868435. PubMed ID: 35509319
[TBL] [Abstract][Full Text] [Related]
48. Urine lipoarabinomannan as a marker for low-risk of NTM infection in the CF airway.
De P; Amin AG; Graham B; Martiniano SL; Caceres SM; Poch KR; Jones MC; Saavedra MT; Malcolm KC; Nick JA; Chatterjee D
J Cyst Fibros; 2020 Sep; 19(5):801-807. PubMed ID: 32624408
[TBL] [Abstract][Full Text] [Related]
49. Non-tuberculous mycobacterial infection among lung transplant recipients: a 15-year cohort study.
Knoll BM; Kappagoda S; Gill RR; Goldberg HJ; Boyle K; Baden LR; Fuhlbrigge AL; Marty FM
Transpl Infect Dis; 2012 Oct; 14(5):452-60. PubMed ID: 22676720
[TBL] [Abstract][Full Text] [Related]
50. Species-Specific Risk Factors, Treatment Decisions, and Clinical Outcomes for Laboratory Isolates of Less Common Nontuberculous Mycobacteria in Washington State.
Ford ES; Horne DJ; Shah JA; Wallis CK; Fang FC; Hawn TR
Ann Am Thorac Soc; 2017 Jul; 14(7):1129-1138. PubMed ID: 28387523
[TBL] [Abstract][Full Text] [Related]
51. [Nontuberculous mycobacterial infections of the lung].
Latshang TD; Lo Cascio CM; Russi EW
Ther Umsch; 2011 Jul; 68(7):402-6. PubMed ID: 21728159
[TBL] [Abstract][Full Text] [Related]
52. Prospective analysis of cystic fibrosis transmembrane regulator mutations in adults with bronchiectasis or pulmonary nontuberculous mycobacterial infection.
Ziedalski TM; Kao PN; Henig NR; Jacobs SS; Ruoss SJ
Chest; 2006 Oct; 130(4):995-1002. PubMed ID: 17035430
[TBL] [Abstract][Full Text] [Related]
53. Clinical symptoms and survival in non-smoking and smoking HIV-negative patients with non-tuberculous mycobacterial isolation.
Kotilainen H; Valtonen V; Tukiainen P; Poussa T; Eskola J; Järvinen A
Scand J Infect Dis; 2011 Mar; 43(3):188-96. PubMed ID: 21162612
[TBL] [Abstract][Full Text] [Related]
54. Nontuberculous mycobacterial infections in cystic fibrosis.
Martiniano SL; Nick JA
Clin Chest Med; 2015 Mar; 36(1):101-15. PubMed ID: 25676523
[TBL] [Abstract][Full Text] [Related]
55. Prevalence and importance of non-tuberculous mycobacteria in adult patients with cystic fibrosis in a hospital in Madrid.
Fernández-Caso B; Vázquez R; Alarcón T; Girón R; López-Giménez MR; Domingo D
Enferm Infecc Microbiol Clin (Engl Ed); 2020; 38(7):323-326. PubMed ID: 31744623
[TBL] [Abstract][Full Text] [Related]
56. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis.
Olivier KN; Weber DJ; Wallace RJ; Faiz AR; Lee JH; Zhang Y; Brown-Elliot BA; Handler A; Wilson RW; Schechter MS; Edwards LJ; Chakraborti S; Knowles MR;
Am J Respir Crit Care Med; 2003 Mar; 167(6):828-34. PubMed ID: 12433668
[TBL] [Abstract][Full Text] [Related]
57. Adult Patients With Bronchiectasis: A First Look at the US Bronchiectasis Research Registry.
Aksamit TR; O'Donnell AE; Barker A; Olivier KN; Winthrop KL; Daniels MLA; Johnson M; Eden E; Griffith D; Knowles M; Metersky M; Salathe M; Thomashow B; Tino G; Turino G; Carretta B; Daley CL;
Chest; 2017 May; 151(5):982-992. PubMed ID: 27889361
[TBL] [Abstract][Full Text] [Related]
58. [Non-tuberculous mycobacterial infection in patients with non-cystic fibrosis bronchiectasias].
Martínez-Cerón E; Prados C; Gómez-Carrera L; Cabanillas JJ; López-López G; Álvarez-Sala R
Rev Clin Esp; 2012 Mar; 212(3):127-30. PubMed ID: 22119262
[TBL] [Abstract][Full Text] [Related]
59. Safety and Effectiveness of Clofazimine for Primary and Refractory Nontuberculous Mycobacterial Infection.
Martiniano SL; Wagner BD; Levin A; Nick JA; Sagel SD; Daley CL
Chest; 2017 Oct; 152(4):800-809. PubMed ID: 28483608
[TBL] [Abstract][Full Text] [Related]
60. Patients with non-tuberculous mycobacteria in respiratory samples: a 5-year epidemiological study.
Matesanz López C; Loras Gallego C; Cacho Calvo J; Thuissard Vasallo IJ; Río Ramírez MT
Rev Esp Quimioter; 2021 Apr; 34(2):120-125. PubMed ID: 33522212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
